Trial NCT01301391

View at ClinicalTrials.gov 
Org. Study IDs: CDKO-125a-007

Last trial update was posted on 2019-02-06

MeSH Interventions

Maleic acid

MeSH Conditions

Thymoma Thymus Neoplasms

Other Conditions

Malignant Thymoma

Stopping Reasons

For the last patient still on treated nominal therapeutic use of the Milciclib was approved at INT Milano.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID